CTI BioPharma Corp. (CTIC)

0.92
NASDAQ : Health Technology
Prev Close 0.89
Day Low/High 0.86 / 0.92
52 Wk Low/High 0.60 / 2.30
Avg Volume 241.80K
Exchange NASDAQ
Shares Outstanding 57.98M
Market Cap 51.34M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of CTIC September 18th Options Trading

First Week of CTIC September 18th Options Trading

Investors in CTI BioPharma Corp saw new options become available this week, for the September 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

April 17th Options Now Available For CTI BioPharma (CTIC)

April 17th Options Now Available For CTI BioPharma (CTIC)

Investors in CTI BioPharma Corp saw new options become available today, for the April 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 91 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Insider Trading Alert - IRET, CTIC And RKUS Traded By Insiders

Insider Trading Alert - IRET, CTIC And RKUS Traded By Insiders

Stocks with insider trader activity include IRET, CTIC and RKUS

Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders

Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders

Stocks with insider trader activity include CTIC, FXCM and CRM

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know

To prep investors for 2015, a list of clinical trial read-outs and FDA events expected to have a significant impact on stock prices in the first half of next year.

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

One biotech CEO won accolades in 2010 only to be razzed for poor performance in 2011.

Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders

Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders

Stocks with insider trader activity include CSU, IRBT and CTIC

Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off

Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off

Let's look back at the stock performance of biotech companies issuing the worst, most pandering press releases from January 2014.

Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders

Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders

Stocks with insider trader activity include CTIC, SAM and DGI

Merrimack Does Well to License Marginal Cancer Drug to Baxter

Merrimack Does Well to License Marginal Cancer Drug to Baxter

Baxter has a hunger for cancer drugs with hair.

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

On 17 occasions, RA Capital bought shares in biotech company financings after having sold short shares of the same company when it was supposed to be restricted from doing so.

Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders

Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders

Stocks with insider trader activity include MTDR, ABCO and CTIC

CTI BioPharma Stock Sees Short Interest Expand By 17%

CTI BioPharma Stock Sees Short Interest Expand By 17%

The most recent short interest data has been released by the NASDAQ for the 07/31/2014 settlement date, which shows a 2,318,023 share increase in total short interest for CTI BioPharma Corp , to 16,071,744, an increase of 16.85% since 07/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders

Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders

Stocks with insider trader activity include CMS, CTIC and WFT

First Week of March 2015 Options Trading For CTI BioPharma (CTIC)

First Week of March 2015 Options Trading For CTI BioPharma (CTIC)

Investors in CTI BioPharma Corp saw new options begin trading this week, for the March 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Insider Trading Alert - AAWW, CTIC And HBI Traded By Insiders

Insider Trading Alert - AAWW, CTIC And HBI Traded By Insiders

Stocks with insider trader activity include AAWW, CTIC and HBI

Insider Trading Alert - FII, RP And CTIC Traded By Insiders

Insider Trading Alert - FII, RP And CTIC Traded By Insiders

Stocks with insider trader activity include FII, RP and CTIC

Insider Trading Alert - FII, RP And CTIC Traded By Insiders

Insider Trading Alert - FII, RP And CTIC Traded By Insiders

Stocks with insider trader activity include FII, RP and CTIC

Short Interest In CTI BioPharma Jumps 29.6%

Short Interest In CTI BioPharma Jumps 29.6%

The most recent short interest data has been released by the NASDAQ for the 06/13/2014 settlement date, which shows a 2,933,833 share increase in total short interest for CTI BioPharma Corp , to 12,847,530, an increase of 29.59% since 05/30/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Short Interest In CTI BioPharma Drops 28.7%

Short Interest In CTI BioPharma Drops 28.7%

The most recent short interest data has been released by the NASDAQ for the 05/30/2014 settlement date, which shows a 3,995,666 share decrease in total short interest for CTI BioPharma Corp , to 9,913,697, a decrease of 28.73% since 05/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders

Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders

Stocks with insider trader activity include MWE, CPT and CTIC

Why Cell Therapeutics (CTIC) Stock Is Spiking Today

Why Cell Therapeutics (CTIC) Stock Is Spiking Today

Cell Therapeutics (CTIC) is rocketing up today after being initiated with a 'buy' rating by analysts at Ladenburg (LTS).

Interesting CTIC Put And Call Options For July 19th

Interesting CTIC Put And Call Options For July 19th

Investors in Cell Therapeutics, Inc. saw new options become available this week, for the July 19th expiration.

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders

Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders

Stocks with insider trader activity include CTIC, KR and IBKR

First Week of CTIC May 17th Options Trading

First Week of CTIC May 17th Options Trading

Investors in Cell Therapeutics, Inc. saw new options begin trading this week, for the May 17th expiration.

Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns

Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns

The FDA's clinical hold placed on Geron's imetelstat means all clinical trials are suspended.

Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders

Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders

Stocks with insider trader activity include CTIC, TCBI and FCS

Interesting CTIC Put And Call Options For April 19th

Interesting CTIC Put And Call Options For April 19th

Investors in Cell Therapeutics, Inc. saw new options begin trading this week, for the April 19th expiration.

NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule

NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule

If history repeats, investor optimism for NewLink's phase III study is misplaced.

TheStreet Quant Rating: D (Sell)